Word: genentech
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Genentech, Inc. will use a Columbia-patented method developed by Professor of Biochemistry and Pathology Richard Axel and colleagues to develop a drug that could help sufferers of heart attacks, The Spectator reported...
Mullinix refused to state the exact amounts the university and the researchers would receive for the license. She said, however, that Genentech had made an immediate cash payment for the right to use the drug, and would also pay royalty fees...
...Genentech Inc. has been purchasing a collection of recorded books for its commuting employees. Having a book read aloud while driving has become an addiction...
...owns the wonder drugs that the biotechnology industry creates through genetic engineering? This is turning out to be a thorny question. As a result, firms may have trouble getting widespread patent protection for their new products. South San Francisco-based Genentech last week lost a significant legal battle when a British high court failed to uphold a patent that the company had received in Britain on t-PA, a substance that dissolves blood clots, a cause of heart attacks. Some industry experts think the British case could be a harbinger of more patent troubles for biotech firms. In the aftermath...
...young industry's setback is likely to be short lived, however. Genentech is expected to win FDA authorization for t-PA, perhaps within a year or so. Says Robert Kupor, an industry analyst with the Seattle-based Cable, Howse & Ragen brokerage firm: "It's great stuff, and there's no doubt it will ultimately be approved." Once that happens, experts expect to see a $1 billion-a-year market for clot-dissolving drugs...